Clinical effect of spleen aminopeptide on improving liver function damage and immune function in children with infant hepatitis syndrome

Table 4 Comparison of clinical efficacy and complications between the two groups [n (%)]

Group	Cure	Improved	Ineffective	Effective	Skin rash	Cough and sputum	Elevated platelets		Gastrointestinal reaction
Control group (50)	24 (48.00)	14 (28.00)	12 (22.00)	38 (76.00)	2 (4.00)	2 (4.00)		1 (2.00)		3 (6.00)
Therapy group (50)	14 (28.00)	35 (70.00)	1 (2.00)	49 (98.00)	0	1 (2.00)		0		1 (2.00)
χ2				10.698						4.000
P value				0.001						0.046